Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 82 (CCDC82) is a human protein encoded by the CCDC82 gene, characterized by a coiled-coil domain structure that facilitates protein-protein interactions[1]. It is mainly predicted to function in the nucleus and is implicated in cellular homeostasis, including roles in the cellular response to DNA damage through ATM-dependent phosphorylation, and in neurodevelopment[2][5]. Pathogenic variants in CCDC82 are linked to severe neurodevelopmental disorders, including syndromic intellectual disability, microcephaly, and spasticity[2][4][5]. While CCDC82 has been studied in the context of various diseases, including neurological, cardiovascular, and cancer-related conditions in research settings, it is not currently established as a therapeutic target, and no direct drug interactions are known[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 82 (CCDC82).